These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 7584719)

  • 1. Haloperidol and restraint differently inhibit the induction of sensitization to the ambulation-increasing effect of methamphetamine in mice.
    Kuribara H
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1995 Jun; 15(3):253-63. PubMed ID: 7584719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial inhibition of reverse tolerance by a high dose of ritanserin or low dose of haloperidol in methamphetamine-sensitized rat.
    Tanaka T; Ishigooka J; Watanabe S; Nagata E; Miura S
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1998 Feb; 18(1):1-7. PubMed ID: 9592805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of haloperidol on the methamphetamine sensitization: assessment by ambulatory activity in mice.
    Kuribara H; Uchihashi Y
    Jpn J Psychiatry Neurol; 1993 Sep; 47(3):661-8. PubMed ID: 8301885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of tetrabenazine on methamphetamine-induced hyperactivity in mice are dependent on order and time-course of administration.
    Kuribara H
    Pharmacol Biochem Behav; 1997 Jan; 56(1):9-14. PubMed ID: 8981603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early post-treatment with haloperidol retards induction of methamphetamine sensitization in mice.
    Kuribara H
    Eur J Pharmacol; 1994 May; 256(3):295-9. PubMed ID: 8045274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Modification of stereotypy-producing and ambulation-increasing effects following repeated administration of methamphetamine in rats].
    Kifune A; Tadokoro S
    Yakubutsu Seishin Kodo; 1991 Jun; 11(3):207-14. PubMed ID: 1771975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in G-protein activity mediated through the stimulation of dopamine and GABA(B) receptors in the mesolimbic dopaminergic system of morphine-sensitized mice.
    Narita M; Shibasaki M; Mizuo K; Suzuki T
    Addict Biol; 2003 Sep; 8(3):319-25. PubMed ID: 13129834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of repeated administration of bromocriptine on ambulatory activity in mice, and changes in methamphetamine sensitivity in bromocriptine-experienced mice].
    Asami T; Kuribara H; Tadokoro S
    Yakubutsu Seishin Kodo; 1986 Sep; 6(3):309-17. PubMed ID: 3811623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effect of restraint on induction of behavioral sensitization to methamphetamine and cocaine in mice.
    Kuribara H
    Pharmacol Biochem Behav; 1996 Jun; 54(2):327-31. PubMed ID: 8743591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can posttreatment with the selective dopamine D2 antagonist, YM-09151-2, inhibit induction of methamphetamine sensitization? Evaluation by ambulatory activity in mice.
    Kuribara H
    Pharmacol Biochem Behav; 1994 Oct; 49(2):323-6. PubMed ID: 7824544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of mosapramine (Y-516), a new dopamine D2 antagonist, on reverse tolerance after repeated administration of methamphetamine by means of the ambulation-increasing effect in mice].
    Uchihashi Y; Morimoto T; Tadokoro S
    Nihon Yakurigaku Zasshi; 1992 Mar; 99(3):153-60. PubMed ID: 1505855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of postmethamphetamine treatment with restraint on ambulatory sensitization to methamphetamine in mice.
    Kuribara H
    Brain Res Bull; 1997; 43(1):97-100. PubMed ID: 9205802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of methamphetamine sensitization by post-methamphetamine treatment with SCH 23390 or haloperidol.
    Kuribara H
    Psychopharmacology (Berl); 1995 May; 119(1):34-8. PubMed ID: 7675947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modification by MK-801 (dizocilpine), a noncompetitive NMDA receptor antagonist, of morphine sensitization: evaluation by ambulation in mice.
    Iijima Y; Asami T; Kuribara H
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1996 Feb; 16(1):11-8. PubMed ID: 8640458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methamphetamine-induced locomotor activity and behavioral sensitization: are dopamine d3 receptors involved?
    Jones CD; Bartee JA; Leite-Browning ML; Blackshear MA
    Cell Mol Biol (Noisy-le-grand); 2007 May; 53(4):15-22. PubMed ID: 17531156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circadian variation in the ambulation-increasing effect of apomorphine after repeated administration in mice.
    Kuribara H; Tadokoro S
    Yakubutsu Seishin Kodo; 1984 Nov; 4(3):231-6. PubMed ID: 6534037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ambulation-increasing effect of buprenorphine in mice: comparison with the effect of morphine.
    Kuribara H; Tadokoro S
    Arukoru Kenkyuto Yakubutsu Ison; 1991 Feb; 26(1):37-48. PubMed ID: 2069536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of 5-HT receptors in the development and expression of methamphetamine-induced behavioral sensitization: 5-HT receptor channel and binding study.
    Yoo JH; Cho JH; Yu HS; Lee KW; Lee BH; Jeong SM; Nah SY; Kim HC; Lee SY; Jang CG
    J Neurochem; 2006 Nov; 99(3):976-88. PubMed ID: 16942594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of methamphetamine-induced behavioral sensitization by repeated administration of a dopamine D1 receptor agonist.
    Shuto T; Kuroiwa M; Hamamura M; Yabuuchi K; Shimazoe T; Watanabe S; Nishi A; Yamamoto T
    Neuropharmacology; 2006 Jun; 50(8):991-7. PubMed ID: 16563442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Behavioral study on an antitussive and expectorant, and of its constituents. II. Effects on ambulatory activity after repeated administration, and a modification of the methamphetamine sensitivity in mice].
    Kuribara H; Tadokoro S
    Arukoru Kenkyuto Yakubutsu Ison; 1989 Oct; 24(5):430-8. PubMed ID: 2624571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.